Growth Metrics

Rapid Micro Biosystems (RPID) EBT Margin Growth (3y) (2023 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin Growth (3y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -305.00
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -9.00
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -222.00
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 923.00
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -480.00
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 2,114.00
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 1,391.00
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -176.00
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 329.00
10 Rapid Micro Biosystems 89.50 Mn 66.56 Mn 371,000.00 9,738.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 9,738.00
Dec 31, 2025 26,521.00
Sep 30, 2025 19,795.00
Jun 30, 2025 19,186.00
Mar 31, 2025 20,212.00
Dec 31, 2024 16,205.00
Sep 30, 2024 21,316.00
Jun 30, 2024 288.00
Mar 31, 2024 20,471.00
Dec 31, 2023 -66,739.00
Sep 30, 2023 -5,682.00
Jun 30, 2023 7,444.00